Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
US Army
Covington
McKinsey
Express Scripts
Medtronic
Cantor Fitzgerald
Baxter
US Department of Justice
Mallinckrodt

Generated: January 16, 2018

DrugPatentWatch Database Preview

MOXATAG Drug Profile

« Back to Dashboard

Which patents cover Moxatag, and when can generic versions of Moxatag launch?

Moxatag is a drug marketed by Vernalis R And D Ltd and is included in one NDA. There are six patents protecting this drug.

This drug has thirty-seven patent family members in six countries.

The generic ingredient in MOXATAG is amoxicillin. There are forty-four drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for MOXATAG
Drug patent expirations by year for MOXATAG
Pharmacology for MOXATAG
Medical Subject Heading (MeSH) Categories for MOXATAG

US Patents and Regulatory Information for MOXATAG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Vernalis R And D Ltd MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for MOXATAG

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,667,057 Levofloxacin antibiotic product, use and formulation thereof ➤ Subscribe
7,108,859 Antineoplastic product, use and formulation thereof ➤ Subscribe
6,541,014 Antiviral product, use and formulation thereof ➤ Subscribe
7,025,989 Multiple-delayed released antibiotic product, use and formulation thereof ➤ Subscribe
8,889,187 Once a day amoxicillin product comprising immediate and delayed release dosage forms ➤ Subscribe
8,303,988 Antifungal once-a-day product, use and formulation thereof ➤ Subscribe
7,157,095 Multiple-delayed release antifungal product, use and formulation thereof ➤ Subscribe
7,282,221 Antiviral product, use and formulation thereof ➤ Subscribe
6,663,890 Metronidazole antibiotic product, use and formulation thereof ➤ Subscribe
6,730,320 Tetracycline antibiotic product, use and formulation thereof ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for MOXATAG

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Cipla
Moodys
Federal Trade Commission
Argus Health
Mallinckrodt
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot